home / stock / evtcy / evtcy quote
Last: | $22.96 |
---|---|
Change Percent: | -0.04% |
Open: | $23.0201 |
Close: | $22.96 |
High: | $23.0201 |
Low: | $22.96 |
Volume: | 344 |
Last Trade Date Time: | 11/03/2021 04:54:47 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$22.96 | $23.0201 | $22.96 | $23.0201 | $22.96 | 344 | 11-03-2021 |
$22.97 | $23.38 | $22.97 | $23.38 | $22.97 | 1,826 | 11-02-2021 |
$24.14 | $24.14 | $24.14 | $24.14 | $24.14 | 676 | 11-01-2021 |
$24 | $24 | $24 | $24 | $24 | 591 | 10-29-2021 |
$24.82 | $24.19 | $24.82 | $24.82 | $24.19 | 520 | 10-28-2021 |
$23.95 | $25.1 | $23.95 | $25.18 | $23.95 | 1,978 | 10-27-2021 |
$24.72 | $25.3 | $24.72 | $25.3 | $24.72 | 462 | 10-26-2021 |
$25.768 | $25.74 | $25.768 | $25.768 | $25.74 | 801 | 10-25-2021 |
$25.72 | $25.75 | $25.72 | $26.57 | $25.72 | 1,326 | 10-21-2021 |
$25.63 | $25.15 | $25.63 | $25.7255 | $25.15 | 1,045 | 10-20-2021 |
$99.9 | $99.9 | $99.9 | $99.9 | $99.9 | 136 | 10-19-2021 |
$97.62 | $97.62 | $97.62 | $97.62 | $97.62 | 222 | 10-18-2021 |
$90.3775 | $91.25 | $90.3775 | $91.25 | $90.3775 | 233 | 10-07-2021 |
$93.8 | $93.8 | $93.8 | $93.8 | $93.8 | 200 | 10-04-2021 |
$95.05 | $95.05 | $95.05 | $95.05 | $95.05 | 379 | 09-29-2021 |
$104.96 | $104.96 | $104.96 | $104.96 | $104.96 | 470 | 09-22-2021 |
$103.44 | $103.44 | $103.44 | $103.44 | $103.44 | 527 | 09-21-2021 |
$105.05 | $105.05 | $105.05 | $105.05 | $105.05 | 258 | 09-16-2021 |
$104.5 | $104.5 | $104.5 | $104.5 | $104.5 | 100 | 09-10-2021 |
$100.05 | $100.05 | $100.05 | $100.05 | $100.05 | 190 | 08-31-2021 |
News, Short Squeeze, Breakout and More Instantly...
Evotec Ag Adr Company Name:
EVTCY Stock Symbol:
OTCMKTS Market:
FINANCIAL RESULTS FOR 2023 FULLY MET UPDATED GUIDANCE PRIORITY RESET TO PROFITABLE GROWTH: SIZE & FOOTPRINT ADJUSTMENTS TO DRIVE EXPECTED ANNUALISED EBITDA IMPROVEMENT GREATER THAN € 40 M EVOTEC'S REPORTING STRUCTURE WILL CHANGE TO BUSINESS SEGMENTS “SHARED R&D&...
HAMBURG, GERMANY / ACCESSWIRE / April 23, 2024 / The Supervisory Board of Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) has appointed Dr Christian Wojczewski as the Company's new Chief Executive Officer ("CEO"), effective 01 July 2024. The election was un...
COLLABORATION LEVERAGES VARIANT BIO'S CUTTING-EDGE GENOMIC DISCOVERY PLATFORM AND EVOTEC'S INTEGRATED END-TO-END R&D PLATFORM AND DISEASE AREA EXPERTISE TO ADDRESS UNMET MEDICAL NEED IN FIBROTIC INDICATIONS COMMERCIAL TERMS INCLUDE RESEARCH FUNDING AND MILESTONES AND/OR ROYALTY PAYMENTS ...